Skip to main content

WELLS FARGO & COMPANY/MN

Position in MGX — Metagenomi Therapeutics, Inc.

CIK 72971 SAN FRANCISCO, CA

Position in MGX

as of Mar 31, 2026 · filed May 11, 2026
Position Value
$270,864
+$79,040 QoQ
Shares Held
202,138
+70.7% QoQ
Ownership
0.537%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in MGX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

WELLS FARGO & COMPANY/MN holds $1,292,861,286 across 390 Biotechnology names. MGX ranks #162 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in MGX

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $270,864 202,138
2025-12-31 $191,824 118,410
2025-09-30 $241,758 102,008
2025-06-30 $145,624 98,396
2025-03-31 $149,555 109,968
2024-12-31 $343,627 95,188
2024-09-30 $133,683 61,606
2024-06-30 $107,352 26,312
2024-03-31 $262,631 24,894